2018-2023 Global Novel Drug Delivery Systems Consumption Market Report

September 2018 | 184 pages | ID: 2A74FF879C4EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Novel Drug Delivery Systems market for 2018-2023.

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.

Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
The classification of Novel Drug Delivery Systems includes Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and the proportion of PEGylated Proteins & Polypeptides in 2017 is about 39.60%, and the proportion is in decreasing trend from 2013 to 2017.
North America is the largest consumption place, with a consumption market share nearly 49.69% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.15%.
Over the next five years, LPI(LP Information) projects that Novel Drug Delivery Systems will register a 2.2% CAGR in terms of revenue, reach US$ 30300 million by 2023, from US$ 26500 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Novel Drug Delivery Systems market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Liposomes
• PEGylated Proteins & Polypeptides
• Polymer Nanoparticle
• Protein–drug Conjugates
• Others

Segmentation by application:

• Hospitals & Clinic
• Cancer Treatment Centers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Amgen
• Teva
• UCB (Union Chimique Belge)
• Roche
• Celgene
• Sanofi
• Merck
• Johnson & Johnson
• Takeda
• Gilead Sciences
• Pfizer
• Dr Reddy
• Samyang Biopharmaceuticals
• TOLMAR
• Astellas
• AMAG Pharmaceuticals
• AstraZeneca
• AbbVie
• Bausch&Lomb
• TWi Pharmaceuticals
• Novartis
• Aspen
• Shire
• Breckenridge Pharmaceuticals
• Galen

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Novel Drug Delivery Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Novel Drug Delivery Systems market by identifying its various subsegments.
• Focuses on the key global Novel Drug Delivery Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Novel Drug Delivery Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Novel Drug Delivery Systems submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Novel Drug Delivery Systems Consumption 2013-2023
  2.1.2 Novel Drug Delivery Systems Consumption CAGR by Region
2.2 Novel Drug Delivery Systems Segment by Type
  2.2.1 Liposomes
  2.2.2 PEGylated Proteins & Polypeptides
  2.2.3 Polymer Nanoparticle
  2.2.4 Protein–drug Conjugates
  2.2.5 Others
2.3 Novel Drug Delivery Systems Consumption by Type
  2.3.1 Global Novel Drug Delivery Systems Consumption Market Share by Type (2013-2018)
  2.3.2 Global Novel Drug Delivery Systems Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Novel Drug Delivery Systems Sale Price by Type (2013-2018)
2.4 Novel Drug Delivery Systems Segment by Application
  2.4.1 Hospitals & Clinic
  2.4.2 Cancer Treatment Centers
  2.4.3 Others
2.5 Novel Drug Delivery Systems Consumption by Application
  2.5.1 Global Novel Drug Delivery Systems Consumption Market Share by Application (2013-2018)
  2.5.2 Global Novel Drug Delivery Systems Value and Market Share by Application (2013-2018)
  2.5.3 Global Novel Drug Delivery Systems Sale Price by Application (2013-2018)

3 GLOBAL NOVEL DRUG DELIVERY SYSTEMS BY PLAYERS

3.1 Global Novel Drug Delivery Systems Sales Market Share by Players
  3.1.1 Global Novel Drug Delivery Systems Sales by Players (2016-2018)
  3.1.2 Global Novel Drug Delivery Systems Sales Market Share by Players (2016-2018)
3.2 Global Novel Drug Delivery Systems Revenue Market Share by Players
  3.2.1 Global Novel Drug Delivery Systems Revenue by Players (2016-2018)
  3.2.2 Global Novel Drug Delivery Systems Revenue Market Share by Players (2016-2018)
3.3 Global Novel Drug Delivery Systems Sale Price by Players
3.4 Global Novel Drug Delivery Systems Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Novel Drug Delivery Systems Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Novel Drug Delivery Systems Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 NOVEL DRUG DELIVERY SYSTEMS BY REGIONS

4.1 Novel Drug Delivery Systems by Regions
  4.1.1 Global Novel Drug Delivery Systems Consumption by Regions
  4.1.2 Global Novel Drug Delivery Systems Value by Regions
4.2 Americas Novel Drug Delivery Systems Consumption Growth
4.3 APAC Novel Drug Delivery Systems Consumption Growth
4.4 Europe Novel Drug Delivery Systems Consumption Growth
4.5 Middle East & Africa Novel Drug Delivery Systems Consumption Growth

5 AMERICAS

5.1 Americas Novel Drug Delivery Systems Consumption by Countries
  5.1.1 Americas Novel Drug Delivery Systems Consumption by Countries (2013-2018)
  5.1.2 Americas Novel Drug Delivery Systems Value by Countries (2013-2018)
5.2 Americas Novel Drug Delivery Systems Consumption by Type
5.3 Americas Novel Drug Delivery Systems Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Novel Drug Delivery Systems Consumption by Countries
  6.1.1 APAC Novel Drug Delivery Systems Consumption by Countries (2013-2018)
  6.1.2 APAC Novel Drug Delivery Systems Value by Countries (2013-2018)
6.2 APAC Novel Drug Delivery Systems Consumption by Type
6.3 APAC Novel Drug Delivery Systems Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Novel Drug Delivery Systems by Countries
  7.1.1 Europe Novel Drug Delivery Systems Consumption by Countries (2013-2018)
  7.1.2 Europe Novel Drug Delivery Systems Value by Countries (2013-2018)
7.2 Europe Novel Drug Delivery Systems Consumption by Type
7.3 Europe Novel Drug Delivery Systems Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Novel Drug Delivery Systems by Countries
  8.1.1 Middle East & Africa Novel Drug Delivery Systems Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Novel Drug Delivery Systems Value by Countries (2013-2018)
8.2 Middle East & Africa Novel Drug Delivery Systems Consumption by Type
8.3 Middle East & Africa Novel Drug Delivery Systems Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Novel Drug Delivery Systems Distributors
10.3 Novel Drug Delivery Systems Customer

11 GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET FORECAST

11.1 Global Novel Drug Delivery Systems Consumption Forecast (2018-2023)
11.2 Global Novel Drug Delivery Systems Forecast by Regions
  11.2.1 Global Novel Drug Delivery Systems Forecast by Regions (2018-2023)
  11.2.2 Global Novel Drug Delivery Systems Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Novel Drug Delivery Systems Forecast by Type
11.8 Global Novel Drug Delivery Systems Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Amgen
  12.1.1 Company Details
  12.1.2 Novel Drug Delivery Systems Product Offered
  12.1.3 Amgen Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Amgen News
12.2 Teva
  12.2.1 Company Details
  12.2.2 Novel Drug Delivery Systems Product Offered
  12.2.3 Teva Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Teva News
12.3 UCB (Union Chimique Belge)
  12.3.1 Company Details
  12.3.2 Novel Drug Delivery Systems Product Offered
  12.3.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 UCB (Union Chimique Belge) News
12.4 Roche
  12.4.1 Company Details
  12.4.2 Novel Drug Delivery Systems Product Offered
  12.4.3 Roche Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Roche News
12.5 Celgene
  12.5.1 Company Details
  12.5.2 Novel Drug Delivery Systems Product Offered
  12.5.3 Celgene Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Celgene News
12.6 Sanofi
  12.6.1 Company Details
  12.6.2 Novel Drug Delivery Systems Product Offered
  12.6.3 Sanofi Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Sanofi News
12.7 Merck
  12.7.1 Company Details
  12.7.2 Novel Drug Delivery Systems Product Offered
  12.7.3 Merck Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Merck News
12.8 Johnson & Johnson
  12.8.1 Company Details
  12.8.2 Novel Drug Delivery Systems Product Offered
  12.8.3 Johnson & Johnson Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Johnson & Johnson News
12.9 Takeda
  12.9.1 Company Details
  12.9.2 Novel Drug Delivery Systems Product Offered
  12.9.3 Takeda Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Takeda News
12.10 Gilead Sciences
  12.10.1 Company Details
  12.10.2 Novel Drug Delivery Systems Product Offered
  12.10.3 Gilead Sciences Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Gilead Sciences News
12.11 Pfizer
12.12 Dr Reddy
12.13 Samyang Biopharmaceuticals
12.14 TOLMAR
12.15 Astellas
12.16 AMAG Pharmaceuticals
12.17 AstraZeneca
12.18 AbbVie
12.19 Bausch＆Lomb
12.20 TWi Pharmaceuticals
12.21 Novartis
12.22 Aspen
12.23 Shire
12.24 Breckenridge Pharmaceuticals
12.25 Galen

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Novel Drug Delivery Systems
Table Product Specifications of Novel Drug Delivery Systems
Figure Novel Drug Delivery Systems Report Years Considered
Figure Market Research Methodology
Figure Global Novel Drug Delivery Systems Consumption Growth Rate 2013-2023 (K Units)
Figure Global Novel Drug Delivery Systems Value Growth Rate 2013-2023 ($ Millions)
Table Novel Drug Delivery Systems Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Liposomes
Table Major Players of Liposomes
Figure Product Picture of PEGylated Proteins & Polypeptides
Table Major Players of PEGylated Proteins & Polypeptides
Figure Product Picture of Polymer Nanoparticle
Table Major Players of Polymer Nanoparticle
Figure Product Picture of Protein–drug Conjugates
Table Major Players of Protein–drug Conjugates
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Novel Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Figure Global Novel Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Table Global Novel Drug Delivery Systems Revenue by Type (2013-2018) ($ million)
Table Global Novel Drug Delivery Systems Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Novel Drug Delivery Systems Value Market Share by Type (2013-2018)
Table Global Novel Drug Delivery Systems Sale Price by Type (2013-2018)
Figure Novel Drug Delivery Systems Consumed in Hospitals & Clinic
Figure Global Novel Drug Delivery Systems Market: Hospitals & Clinic (2013-2018) (K Units)
Figure Global Novel Drug Delivery Systems Market: Hospitals & Clinic (2013-2018) ($ Millions)
Figure Global Hospitals & Clinic YoY Growth ($ Millions)
Figure Novel Drug Delivery Systems Consumed in Cancer Treatment Centers
Figure Global Novel Drug Delivery Systems Market: Cancer Treatment Centers (2013-2018) (K Units)
Figure Global Novel Drug Delivery Systems Market: Cancer Treatment Centers (2013-2018) ($ Millions)
Figure Global Cancer Treatment Centers YoY Growth ($ Millions)
Figure Novel Drug Delivery Systems Consumed in Others
Figure Global Novel Drug Delivery Systems Market: Others (2013-2018) (K Units)
Figure Global Novel Drug Delivery Systems Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Novel Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Figure Global Novel Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Table Global Novel Drug Delivery Systems Value by Application (2013-2018)
Table Global Novel Drug Delivery Systems Value Market Share by Application (2013-2018)
Figure Global Novel Drug Delivery Systems Value Market Share by Application (2013-2018)
Table Global Novel Drug Delivery Systems Sale Price by Application (2013-2018)
Table Global Novel Drug Delivery Systems Sales by Players (2016-2018) (K Units)
Table Global Novel Drug Delivery Systems Sales Market Share by Players (2016-2018)
Figure Global Novel Drug Delivery Systems Sales Market Share by Players in 2016
Figure Global Novel Drug Delivery Systems Sales Market Share by Players in 2017
Table Global Novel Drug Delivery Systems Revenue by Players (2016-2018) ($ Millions)
Table Global Novel Drug Delivery Systems Revenue Market Share by Players (2016-2018)
Figure Global Novel Drug Delivery Systems Revenue Market Share by Players in 2016
Figure Global Novel Drug Delivery Systems Revenue Market Share by Players in 2017
Table Global Novel Drug Delivery Systems Sale Price by Players (2016-2018)
Figure Global Novel Drug Delivery Systems Sale Price by Players in 2017
Table Global Novel Drug Delivery Systems Manufacturing Base Distribution and Sales Area by Players
Table Players Novel Drug Delivery Systems Products Offered
Table Novel Drug Delivery Systems Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Novel Drug Delivery Systems Consumption by Regions 2013-2018 (K Units)
Table Global Novel Drug Delivery Systems Consumption Market Share by Regions 2013-2018
Figure Global Novel Drug Delivery Systems Consumption Market Share by Regions 2013-2018
Table Global Novel Drug Delivery Systems Value by Regions 2013-2018 ($ Millions)
Table Global Novel Drug Delivery Systems Value Market Share by Regions 2013-2018
Figure Global Novel Drug Delivery Systems Value Market Share by Regions 2013-2018
Figure Americas Novel Drug Delivery Systems Consumption 2013-2018 (K Units)
Figure Americas Novel Drug Delivery Systems Value 2013-2018 ($ Millions)
Figure APAC Novel Drug Delivery Systems Consumption 2013-2018 (K Units)
Figure APAC Novel Drug Delivery Systems Value 2013-2018 ($ Millions)
Figure Europe Novel Drug Delivery Systems Consumption 2013-2018 (K Units)
Figure Europe Novel Drug Delivery Systems Value 2013-2018 ($ Millions)
Figure Middle East & Africa Novel Drug Delivery Systems Consumption 2013-2018 (K Units)
Figure Middle East & Africa Novel Drug Delivery Systems Value 2013-2018 ($ Millions)
Table Americas Novel Drug Delivery Systems Consumption by Countries (2013-2018) (K Units)
Table Americas Novel Drug Delivery Systems Consumption Market Share by Countries (2013-2018)
Figure Americas Novel Drug Delivery Systems Consumption Market Share by Countries in 2017
Table Americas Novel Drug Delivery Systems Value by Countries (2013-2018) ($ Millions)
Table Americas Novel Drug Delivery Systems Value Market Share by Countries (2013-2018)
Figure Americas Novel Drug Delivery Systems Value Market Share by Countries in 2017
Table Americas Novel Drug Delivery Systems Consumption by Type (2013-2018) (K Units)
Table Americas Novel Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Figure Americas Novel Drug Delivery Systems Consumption Market Share by Type in 2017
Table Americas Novel Drug Delivery Systems Consumption by Application (2013-2018) (K Units)
Table Americas Novel Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Figure Americas Novel Drug Delivery Systems Consumption Market Share by Application in 2017
Figure United States Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure United States Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Canada Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Canada Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Mexico Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Mexico Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Table APAC Novel Drug Delivery Systems Consumption by Countries (2013-2018) (K Units)
Table APAC Novel Drug Delivery Systems Consumption Market Share by Countries (2013-2018)
Figure APAC Novel Drug Delivery Systems Consumption Market Share by Countries in 2017
Table APAC Novel Drug Delivery Systems Value by Countries (2013-2018) ($ Millions)
Table APAC Novel Drug Delivery Systems Value Market Share by Countries (2013-2018)
Figure APAC Novel Drug Delivery Systems Value Market Share by Countries in 2017
Table APAC Novel Drug Delivery Systems Consumption by Type (2013-2018) (K Units)
Table APAC Novel Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Figure APAC Novel Drug Delivery Systems Consumption Market Share by Type in 2017
Table APAC Novel Drug Delivery Systems Consumption by Application (2013-2018) (K Units)
Table APAC Novel Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Figure APAC Novel Drug Delivery Systems Consumption Market Share by Application in 2017
Figure China Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure China Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Japan Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Japan Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Korea Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Korea Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure India Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure India Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Australia Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Australia Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Table Europe Novel Drug Delivery Systems Consumption by Countries (2013-2018) (K Units)
Table Europe Novel Drug Delivery Systems Consumption Market Share by Countries (2013-2018)
Figure Europe Novel Drug Delivery Systems Consumption Market Share by Countries in 2017
Table Europe Novel Drug Delivery Systems Value by Countries (2013-2018) ($ Millions)
Table Europe Novel Drug Delivery Systems Value Market Share by Countries (2013-2018)
Figure Europe Novel Drug Delivery Systems Value Market Share by Countries in 2017
Table Europe Novel Drug Delivery Systems Consumption by Type (2013-2018) (K Units)
Table Europe Novel Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Figure Europe Novel Drug Delivery Systems Consumption Market Share by Type in 2017
Table Europe Novel Drug Delivery Systems Consumption by Application (2013-2018) (K Units)
Table Europe Novel Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Figure Europe Novel Drug Delivery Systems Consumption Market Share by Application in 2017
Figure Germany Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Germany Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure France Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure France Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure UK Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure UK Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Italy Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Italy Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Russia Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Russia Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Spain Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Spain Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Novel Drug Delivery Systems Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Novel Drug Delivery Systems Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Novel Drug Delivery Systems Consumption Market Share by Countries in 2017
Table Middle East & Africa Novel Drug Delivery Systems Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Novel Drug Delivery Systems Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Novel Drug Delivery Systems Value Market Share by Countries in 2017
Table Middle East & Africa Novel Drug Delivery Systems Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Novel Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Novel Drug Delivery Systems Consumption Market Share by Type in 2017
Table Middle East & Africa Novel Drug Delivery Systems Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Novel Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Novel Drug Delivery Systems Consumption Market Share by Application in 2017
Figure Egypt Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Egypt Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure South Africa Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure South Africa Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Israel Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Israel Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Turkey Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure Turkey Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Novel Drug Delivery Systems Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Novel Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Table Novel Drug Delivery Systems Distributors List
Table Novel Drug Delivery Systems Customer List
Figure Global Novel Drug Delivery Systems Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Novel Drug Delivery Systems Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Novel Drug Delivery Systems Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Novel Drug Delivery Systems Consumption Market Forecast by Regions
Table Global Novel Drug Delivery Systems Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Novel Drug Delivery Systems Value Market Share Forecast by Regions
Figure Americas Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Americas Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure APAC Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure APAC Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Europe Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Europe Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Middle East & Africa Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Middle East & Africa Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure United States Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure United States Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Canada Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Canada Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Mexico Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Mexico Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Brazil Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Brazil Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure China Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure China Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Japan Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Japan Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Korea Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Korea Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Southeast Asia Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Southeast Asia Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure India Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure India Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Australia Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Australia Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Germany Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Germany Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure France Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure France Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure UK Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure UK Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Italy Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Italy Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Russia Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Russia Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Spain Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Spain Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Egypt Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Egypt Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure South Africa Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure South Africa Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Israel Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Israel Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Turkey Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure Turkey Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure GCC Countries Novel Drug Delivery Systems Consumption 2018-2023 (K Units)
Figure GCC Countries Novel Drug Delivery Systems Value 2018-2023 ($ Millions)
Table Global Novel Drug Delivery Systems Consumption Forecast by Type (2018-2023) (K Units)
Table Global Novel Drug Delivery Systems Consumption Market Share Forecast by Type (2018-2023)
Table Global Novel Drug Delivery Systems Value Forecast by Type (2018-2023) ($ Millions)
Table Global Novel Drug Delivery Systems Value Market Share Forecast by Type (2018-2023)
Table Global Novel Drug Delivery Systems Consumption Forecast by Application (2018-2023) (K Units)
Table Global Novel Drug Delivery Systems Consumption Market Share Forecast by Application (2018-2023)
Table Global Novel Drug Delivery Systems Value Forecast by Application (2018-2023) ($ Millions)
Table Global Novel Drug Delivery Systems Value Market Share Forecast by Application (2018-2023)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Amgen Novel Drug Delivery Systems Market Share (2016-2018)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Novel Drug Delivery Systems Market Share (2016-2018)
Table UCB (Union Chimique Belge) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure UCB (Union Chimique Belge) Novel Drug Delivery Systems Market Share (2016-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Roche Novel Drug Delivery Systems Market Share (2016-2018)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Celgene Novel Drug Delivery Systems Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Novel Drug Delivery Systems Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Novel Drug Delivery Systems Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Novel Drug Delivery Systems Market Share (2016-2018)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Takeda Novel Drug Delivery Systems Market Share (2016-2018)
Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Gilead Sciences Novel Drug Delivery Systems Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr Reddy Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Samyang Biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TOLMAR Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AMAG Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bausch＆Lomb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TWi Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aspen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Breckenridge Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galen Basic Information, Manufacturing Base, Sales Area and Its Competitors